ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00144781
Brief Title: A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) Disease

First Submitted : September 2, 2005
First Submitted that Met QC Criteria : September 2, 2005
First Posted : September 5, 2005 (Estimate)

Results First Submitted : March 27, 2009
Results First Submitted that Met QC Criteria : April 27, 2009
Results First Posted : June 16, 2009 (Estimate)

Last Update Submitted that Met QC Criteria : March 17, 2015
Last Update Posted : April 3, 2015 (Estimate)